← ANALYST RATINGS · TIPRANKS
Kardigan, Inc. (KARD): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy0 Hold0 Sell
Ratings of 1 analysts in the last 3 months · top analysts only12-month forecast
Based on 1 price targets given in the last 3 months, the average target is $46.00, the highest $46.00, the lowest $46.00. The average is +253.0% from the last price of $13.03.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Sharon Zackfia★★★★★★★★★★#4054 · hits 44% · avg +3.0% | William Blair | $38.00 | Buy | +191.6% | Initiated | 15.10.26on TipRanks Oct 16 05:55 | +2.4%next day −5.0% | ↗ |
| Name not given | — | $25.00 | Buy | +91.9% | Initiated | 11.10.26on TipRanks Oct 12 05:55 | −2.1%next day −9.6% | ↗ |
| Anupam Rama★★★★★★★★★★#291 · hits 54% · avg +23.3% | J.P. Morgan | $51.00 → $46.00−9.8% | Buy | +253.0% | Assigned | 25.08.26on TipRanks 08:10 | +1.0%next day +1.2% · 5 days −5.8% | ↗ |
| Roanna Ruiz★★★★★★★★★★#9351 · hits 46% · avg −0.3% | Leerink Partners | $37.00 | Buy | +184.0% | Initiated | 13.07.26on TipRanks 07:51 | −3.7%next day −5.8% · 5 days −8.1% | ↗ |
| Ritu Baral★★★★★★★★★★#49 · hits 58% · avg +46.9% | TD Cowen | $46.00 | Buy | +253.0% | Initiated | 13.07.26on TipRanks 05:55 | −3.7%next day −5.8% · 5 days −8.1% | ↗ |
| Dennis Ding★★★★★★★★★★#2230 · hits 58% · avg +12.3% | Jefferies | $40.00 | Buy | +207.0% | Initiated | 13.07.26on TipRanks 05:40 | −3.7%next day −5.8% · 5 days −8.1% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Kardigan, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $42.25 at a price of $14.75 (+186.4%); now: $36.33 at $13.03 (+178.8%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 3 | 4 | 4 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Best top-analyst consensus in the sector · Healthcare
About Kardigan, Inc.
- CEO: Tassos Gianakakos
- Employees: 241
- 506 Carnegie Center Drive, Princeton, NJ, 08540, US
- www.kardigan.bio
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Data from the stock’s TipRanks forecast page, read 5 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗